Molecular Therapy: Oncology
Издатель: Elsevier · ISSN 2950-3299 · 83 статей
- Eradication of pre-clinical prostate tumors by a lentiviral vector-based immunotherapy
- ICAM1-targeted costimulation extends HER2 CAR T cytotoxicity to HER2-low and HER2-negative tumors through synergy with TCR signaling
- Synergistic cell-cycle repression by HDAC/EZH2 co-targeting in H3K27-altered diffuse midline glioma
- Simultaneous targeting of IL-10 and PD-(L)1 pathways with a bispecific anti-PD-L1/IL-10-trap antibody enhances T cell responses
- Selective Inhibition of EGFR-mutant Lung Cancer Cell Proliferation by CRISPR/Cas9 Targeting
- Engineered indoleamine 2,3-dioxygenase variant: Oxidative activation of prodrug indole-3-acetic acid against cancer cells for targeted therapy
- CAR design equips diverse immune cells with unique antigen-specific activation identities
- Prevention of HNSCC by chewing gum delivery of enzymes/antimicrobials to reduce carcinogenic acetaldehyde produced by pathogenic microbes
- An inducible signal 1 booster overcomes limited access to antigen for solid tumor cell therapy
- IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting
- StagX1, an isoquinolinone compound, selectively targets CES1-positive Ewing sarcoma cells as a potential therapeutic agent
- Additive effect of Ruta graveolens bioactive phytoconstituents and cisplatin through PKC/MEK/ERK pathway in glioblastoma
- Ultrasound controllable and antigen-independent killing via cis-activating CAR T cells
- Therapeutic targeting of cancer-associated fibroblasts with oncolytic virus in preclinical models of intrahepatic cholangiocarcinoma
- USP15 regulates mitotic fidelity, metastatic potential, and chemotherapeutic response in ovarian cancer cells
- Targeting LKB1-inactivated lung cancers with a stapled peptide inhibitor of the CRTC-CREB pathway
- Comprehensive preclinical evaluation of second-generation miRNA-regulated Coxsackievirus B3-BHP: Potent antitumor efficacy and safety
- A p53R273H-selective bispecific T cell engager: Computational design and functional validation
- Targeting AATF reprograms the tumor microenvironment and suppresses hepatocellular carcinoma via MIR100HG-TGF-β signaling
- Intramuscular plasmid DNA electroporation sequesters neoantigen-specific CD8+ T cells in treated muscle and limits tumor infiltration
- AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer
- An engineered PD-1 receptor-based CAR that binds anti-PD-1 antibodies but not PD-L1 to enhance T-cell functionality
- Multi-level systems analysis identifies XPO1 as a druggable target linked to NFκB activation, tumor clonality and long-term survival in Adult T-cell Leukemia
- CXCR2 enhances the migration-independent efficacy of pan-cancer CAR-T cells
- Novel TCR-T cells targeting WT137-45 demonstrating anti-cancer reactivity
- Impact of sex differences on metronomic chemotherapy efficacy in oral squamous cell carcinoma patients
- Palmitoyl-protein thioesterase 1, PPT1: from a key enzyme driving the autophagy process to a promising target for drug development in cancer
- Statin-driven reversal of Sunitinib resistance through protein prenylation-blockade in clear cell renal cell carcinoma
- Surgical stress-induced hepatic regulatory T cells promote the development of colorectal liver metastases
- Gene therapy as an upcoming technique in the treatment of cancer: A cellular solution to a cellular problem